TradeOrgs
  • Stocks
  • Screener
  • Backtest
  • Watchlist
  • Signals
  • Portfolio
  • Insights
  • Connect
Sign in
RELIANCE₹1,304.00▼ 0.70%TCS₹2,093.50▼ 6.61%HDFCBANK₹801.05▲ 6.29%ICICIBANK₹1,411.40▲ 13.64%INFY₹1,047.20▼ 14.35%HINDUNILVR₹2,201.20▲ 5.29%ITC₹289.95▲ 4.68%SBIN₹1,040.00▲ 7.17%BHARTIARTL₹1,910.40▲ 4.73%KOTAKBANK₹396.75▲ 4.13%LT₹4,026.60▲ 1.86%AXISBANK₹1,342.10▲ 6.92%ASIANPAINT₹2,737.80▲ 2.83%MARUTI₹14,366.00▲ 10.13%AAPL$308.63▼ 2.08%MSFT$390.49▼ 11.52%GOOGL$359.91▼ 0.54%AMZN$242.67▼ 5.40%NVDA$194.83▼ 12.56%META$582.90▼ 2.46%TSLA$393.45▼ 7.15%BRK-B$507.78▲ 7.69%JPM$334.47▲ 11.13%V$362.13▲ 14.12%
RELIANCE₹1,304.00▼ 0.70%TCS₹2,093.50▼ 6.61%HDFCBANK₹801.05▲ 6.29%ICICIBANK₹1,411.40▲ 13.64%INFY₹1,047.20▼ 14.35%HINDUNILVR₹2,201.20▲ 5.29%ITC₹289.95▲ 4.68%SBIN₹1,040.00▲ 7.17%BHARTIARTL₹1,910.40▲ 4.73%KOTAKBANK₹396.75▲ 4.13%LT₹4,026.60▲ 1.86%AXISBANK₹1,342.10▲ 6.92%ASIANPAINT₹2,737.80▲ 2.83%MARUTI₹14,366.00▲ 10.13%AAPL$308.63▼ 2.08%MSFT$390.49▼ 11.52%GOOGL$359.91▼ 0.54%AMZN$242.67▼ 5.40%NVDA$194.83▼ 12.56%META$582.90▼ 2.46%TSLA$393.45▼ 7.15%BRK-B$507.78▲ 7.69%JPM$334.47▲ 11.13%V$362.13▲ 14.12%

TradeOrgs shows market information and analyzes your own trading history. It does not place trades and is not investment advice.

Prices and listings are for information only. We are read-only against your broker account.

Technical signals (RSI, MACD, etc.) are educational readouts of public indicators — not recommendations.

Privacy Policy·© 2026 TradeOrgs

← All stocks

🇮🇳AMBALALSA

AMBALALSA

NSE
₹32.82
▼ ₹2.95 (-8.2%)
Live· just now
delayed feed · not for order timing

Price history · 20-day (cyan) / 50-day (purple) avg

as of 03 Jul 2026
H ₹38.50L ₹30.30-1.6%
₹38.5₹36.86₹35.22₹33.58₹31.94₹30.3₹32.82
RSI (14)
Intraday · 15-minStrong buy+45RSI 56UptrendMACD Bullishfor day-trading context — not advice

Technical signal

Buy+30
RSI (14)52
oversold 30overbought 70
Trend
Sideways
MACD
Bullish
Bollinger
Within bands
vs 20-day
above
vs 50-day
above
vs 200-day
—
Support
₹30.61
Resistance
₹35.49
  • Price is above its 50-day average (medium-term uptrend).
  • MACD just crossed bullish (momentum turning up).

About Ambalal Sarabhai Enterprises Limited· Drug Manufacturers - Specialty & Generic

source: yahoo

Ambalal Sarabhai Enterprises Limited, together with its subsidiaries, manufactures, markets, and supplies pharmaceutical products in India and internationally. The company offers products for oncology, infertility, and uro-gynaec areas; generic and veterinary products; antifungal active ingredient products; vitamin C coated products; and analytical, test, and measuring instruments, as well as supplies finished dosage forms and active pharmaceutical ingredients. It also provides broadcast and professional video/audio, and electronic products. Ambalal Sarabhai Enterprises Limited was incorporated in 1977 and is based in Ahmedabad, India.

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Headquarters
Ahmedabad, India
www.ase.life ↗

Fundamentals

source: yahoo
Market cap
—
P/E
14.1
P/B
1.6
EPS
₹2.32
Div yield
—
Profit margin
8.8%
ROE
11.9%
Debt / Equity
0.36
Beta
-0.01
52-week range
₹30.30 – ₹38.50
52-week low · ₹30.3031% of rangehigh · ₹38.50

Fundamental data is informational only — not investment advice.

Recent news

News sentiment:▲ Positive2↑ · 0↓ · 6–
  • Tennessee deputy spent seized drug money on Apple gear for his family — now he owes $339K in pension clawbacks— Neutral
    Moneywise · 04 Jul 2026
  • Chery Auto's Rosslyn Plant Opens in South Africa, LEPAS Rides Momentum to Accelerate Local Expansion▲ Positive
    GlobeNewswire · 04 Jul 2026
  • Jim Cramer on Cardinal Health: “It’s Been a Real Stalwart, and I Don’t Think It’s Done”— Neutral
    Insider Monkey · 04 Jul 2026
  • Jim Cramer Says He Bets “The Gains in CVS Will Be Long-Lasting”

Educational technical indicators — not investment advice. TradeOrgs does not place trades.

▲ Positive
Insider Monkey · 04 Jul 2026
  • Jim Cramer Says He Would Avoid Blue Owl and Prefers Blackstone— Neutral
    Insider Monkey · 04 Jul 2026
  • Jim Cramer on Palantir: “This Is the Fastest Grower of the Stocks I Follow, and It’s Been Crushed”— Neutral
    Insider Monkey · 04 Jul 2026
  • Sentiment is a keyword-based read of the headline — a rough signal, not advice.